highmobl
group
protein
hmgb
small
dnabind
protein
serv
import
role
transcript
regul
one
protein
amphoterin
identifi
lateact
mediat
lipopolysaccharid
lp
induc
sepsisinduc
lethal
mice
addit
role
nonhiston
nuclear
protein
also
function
inflammatori
cytokin
passiv
releas
necrot
cell
activ
secret
stressreceiv
cell
monocytesmacrophag
respons
endotoxin
tumor
necrosi
factor
tnf
interleukin
il
releas
intravascular
space
potenti
amplifi
local
inflammatori
respons
enhanc
releas
cytokin
chemokin
stress
cell
interact
endotheli
cell
upregul
surfac
receptor
caus
secret
solubl
proinflammatori
mediat
extracellular
function
damageassoci
molecular
pattern
damp
molecul
activ
proinflammatori
signal
pathway
enhanc
pattern
recognit
receptor
includ
tolllik
receptor
receptor
advanc
glycat
endproduct
rage
mount
evid
suggest
may
also
function
facilit
recognit
immun
coactiv
lp
dna
greedi
bind
molecul
examin
hepat
protect
compound
acut
hepat
injuri
induc
intraven
inject
combin
small
dose
lipopolysaccharid
lp
dgalactosamin
galn
wide
use
anim
model
sinc
hepat
lesion
model
resembl
human
hepat
report
upon
stimul
lp
activ
macrophag
secret
variou
proinflammatori
cytokin
includ
among
key
mediat
caus
hepat
apoptosi
necrosi
lpsgalninduc
liver
failur
number
apoptot
cell
level
serum
concentr
well
alanin
aminotransferas
alt
significantli
increas
administr
lpsgaln
howev
glycyrrhizin
gl
effect
product
cytokin
wherea
inhibit
signific
increas
alt
level
apoptot
cell
number
gl
biolog
activ
substanc
extract
licoric
root
glycyrrhiza
spp
use
folk
medicin
consist
one
molecul
glycyrrhetin
acid
two
glucuron
acid
variou
pharmacolog
effect
gl
well
known
antiinflammatori
antivir
antiallerg
activ
hepatocyt
prolifer
hepatoprotect
intraven
administr
gl
improv
alt
level
patient
chronic
hepat
especi
japan
stronger
neo
minophagen
c
snmc
use
remedi
patient
hepat
c
gl
main
compound
snmc
effect
safeti
snmc
assess
europ
addit
research
use
nuclear
magnet
reson
nmr
fluoresc
method
report
addit
mechan
gl
bound
directli
inhibit
chemoattract
mitogen
activ
accord
recent
studi
furthermor
gl
inhibit
cell
prolifer
migrat
stimul
well
format
blood
vessel
reduc
inflammatori
infiltr
previou
find
demonstr
oxid
stress
hepatocyt
lead
earli
shuttl
nucleu
cytoplasm
attend
subsequ
releas
absenc
cell
death
although
passiv
releas
follow
necrosi
pathway
govern
releas
hepatocyt
known
involv
activ
calcium
signal
calciumcalmodulindepend
protein
kinas
camk
cell
type
downstream
event
govern
releas
link
oxidationreduct
posttransl
modif
includ
phosphoryl
acetyl
howev
lpsgalnimpair
liver
unknown
posttransl
modif
regul
releas
hepatocyt
releas
stress
necrot
cell
might
use
character
cellular
express
bloodstream
kinet
lpsgalninduc
liver
injuri
purpos
studi
investig
posttransl
pathway
regul
nuclear
shuttl
cytoplasm
subsequ
releas
liver
intox
lpsgaln
furthermor
aim
evalu
effect
gl
inhibitor
upon
expand
kinet
experiment
hepat
mice
treat
lpsgain
male
mice
balbc
strain
weigh
g
age
week
purchas
japan
slc
hamamatsu
japan
anim
maintain
environment
control
room
humid
altern
lightdark
cycl
experi
approv
ethic
committe
anim
experi
tsurumi
univers
school
dental
medicin
permit
number
conform
guidelin
establish
guid
care
use
experiment
anim
complianc
nation
act
welfar
manag
anim
lipopolysaccharid
lp
escherichia
coli
dgalactosamin
galn
purchas
sigmaaldrich
st
loui
mo
drug
dissolv
pyrogenfre
salin
glycyrrhizin
gl
obtain
medic
chemistri
research
depart
minophagen
pharmaceut
co
ltd
balbc
mice
intraven
inject
ng
lp
mg
galn
per
mous
h
lpsgalntreat
mice
anesthet
intraperiton
inject
mixtur
mgkg
medetomidin
domitor
zenyaku
co
ltd
tokyo
japan
mgkg
midazolam
midazolam
sandoz
tokyo
japan
mgkg
butorphanol
vetorphal
meiji
seika
pharma
co
ltd
tokyo
japan
collect
blood
cardiac
punctur
intraperiton
administr
gl
mgkg
bodi
weight
perform
min
lpsgalntreat
control
mice
receiv
equal
volum
salin
effect
gl
liver
damag
examin
h
lpsgalntreat
hepatocellular
damag
assess
measur
serum
alanin
aminotransferas
alt
aspart
aminotransferas
ast
use
spot
chem
analyz
arkray
kyoto
japan
serum
measur
elisa
use
commerci
avail
kit
elisa
kit
ii
shinotest
sagamihara
japan
follow
manufactur
instruct
sensit
assay
ngml
stage
h
treatment
mice
sacrif
narcosi
collect
blood
heart
punctur
entir
liver
quickli
remov
tissu
block
dissect
thick
mm
specimen
fix
phosphat
buffer
ph
paraformaldehyd
embed
paraffin
wax
dehydr
grade
ethanol
seri
section
thick
stain
hematoxylin
eosin
immunohistochem
identif
highmobl
group
box
protein
lysin
acetyl
streptavidinbiotinperoxidas
complex
sab
method
appli
addit
perform
heat
mediat
antigen
retriev
via
pressur
cooker
commenc
immunohistochem
stain
protocol
specif
cellular
popul
stain
rabbit
polyclon
antibodi
abcam
lnc
cambridg
uk
acetyl
lysin
abcam
abcam
local
antigen
distinct
cell
type
doubl
immunofluoresc
stain
perform
use
follow
antibodi
rabbit
polyclon
antibodi
rat
monoclon
antibodi
abcam
recogn
cytoplasm
antigen
monocytederiv
macrophag
kupffer
cell
rabbit
hamster
monoclon
antimous
abcam
secondari
antibodi
doubleimmunofluoresc
label
alexa
fluor
green
goat
antirat
igg
invitrogen
antibodi
alexa
fluor
green
goat
antihamst
igg
invitrogen
antibodi
alexa
fluor
red
goat
antirabbit
igg
invitrogen
anti
antibodi
use
counterstain
dapi
roch
diagnost
basel
switzerland
stain
section
mount
crystalmount
biomeda
foster
ctiy
ca
observ
fluoresc
microscop
keyenc
tokyo
japan
two
type
immunohistochem
control
use
section
process
replac
primari
antibodi
normal
nonimmun
serum
section
process
replac
primari
antibodi
irrelev
antibodi
gfp
invitrogen
immunoreact
complet
absent
control
section
evalu
express
grade
acetyl
hepatocyt
acetylatedlysineposit
stain
nuclei
acetylatedlysin
hepatocyt
count
two
highpow
field
x
per
mous
stage
result
express
percentag
total
number
hepatocut
nuclei
randomli
select
highpow
field
pericentr
region
control
lpsgaln
gl
lpsgalntreat
group
n
mice
per
stage
pericentr
region
defin
zone
locat
within
wall
central
vein
mg
frozen
liver
tissu
cut
small
piec
use
scalpel
place
ml
microcentrifug
tube
qproteom
cell
compart
kit
qiagen
hilden
germani
use
accord
manufactur
protocol
nuclear
cytosol
protein
respect
collect
store
protein
concentr
determin
pierc
bca
protein
assay
reagent
kit
takara
bio
inc
shiga
japan
hdac
activ
colorimetr
assay
kit
abcam
use
accord
manufactur
protocol
briefli
nuclear
cytosol
protein
dilut
final
volum
place
round
bottom
plate
assay
buffer
ad
cell
follow
hdac
colorimetr
substrat
mixtur
incub
h
lysin
develop
ad
plate
incub
min
sampl
read
elisa
plate
reader
nm
nuclear
dna
fragment
apoptot
cell
label
situ
termin
deoxynucleotidyl
transferasemedi
dutp
nick
end
label
tunel
method
treat
mgml
proteinas
k
roch
diagnost
section
incub
uml
termin
deoxynucleotidyl
transferas
invitrogen
nm
biotinyl
dutp
roch
diagnost
termin
deoxynucleotidyl
transferas
buffer
invitrogen
rins
section
incub
peroxidaseconjug
streptavidin
dako
dilut
pb
peroxidas
activ
visual
dab
sigmaaldrich
contain
count
tunelposit
cell
distribut
pericentr
region
see
abovement
item
control
lpsgaln
gllpsgalntreat
group
clearli
stain
paraffin
section
lightmicroscop
level
four
five
mous
liver
per
group
examin
number
label
cell
determin
one
six
field
per
liver
size
area
measur
use
imag
processor
analyz
dme
ratoc
tokyo
cellular
densiti
express
cell
number
per
squar
millimet
rna
extract
amplif
section
thick
prepar
paraffinembed
specimen
fix
bufferedparaformaldehyd
deparaffin
tissu
treat
proteinas
k
overnight
follow
centrifug
supernat
process
silicabas
spin
column
toray
industri
inc
tokyo
japan
order
obtain
purifi
total
rna
degre
rna
crosslink
rna
degrad
analyz
electrophoresi
use
agil
bioanalyz
agil
technolog
santa
clara
ca
mg
total
rna
amplifi
use
ffpe
gene
express
analysi
reagent
kit
toray
industri
inc
prepar
launch
accord
manufactur
instruct
amplifi
antisens
rna
arna
label
cyanin
ge
healthcar
subject
hybrid
hybrid
mg
rna
solut
appli
mous
oligo
chip
k
toray
industri
inc
distinct
gene
hybrid
h
accord
manufactur
instruct
hybrid
signal
obtain
use
scanner
toray
industri
inc
process
extract
toray
industri
inc
signal
gene
normal
use
global
normal
method
median
ratio
semiquantit
analysi
rage
tolllik
receptor
mrna
realtim
pcr
perform
control
lpsgaln
gl
lpsgaln
group
anim
sacrif
liver
separ
total
rna
sampl
extract
use
trizol
invitrogen
made
cdna
superscript
iii
firststrand
synthesi
system
rtpcr
invitrogen
accord
manufactur
instruct
primer
sequenc
rage
describ
follow
forward
revers
rage
probe
rage
probe
univers
probe
librari
roch
diagnost
respect
use
fast
start
univers
probe
master
roch
diagnost
pcr
reagent
pcr
reaction
observ
use
appli
biosystem
fast
realtim
pcr
system
appli
biosystem
carlsbad
ca
pcr
condit
follow
min
min
cycl
second
min
actb
use
intern
control
univers
probe
librari
mous
actb
gene
assay
roch
diagnost
chip
assay
conduct
use
epiquick
tissu
chromatin
immunoprecipit
kit
epigentek
brooklyn
ny
accord
manufactur
instruct
rabbit
polyclon
antibodi
abcam
immunoprecipit
chromatin
analyz
duplic
pcr
use
primer
mous
promot
bind
site
identifi
use
transcript
factor
search
web
site
http
wwwcbrcjpresearchdbtfsearchhtml
clone
pcr
product
vector
use
ta
clone
kit
invitrogen
sequenc
pcr
product
confirm
data
show
mean
standard
error
mean
sem
grubb
smirnov
method
use
exclud
outlier
statist
signific
differ
lpsgalntreat
group
test
group
evalu
ttest
pool
standard
divis
final
correct
p
valu
adjust
bonferroni
method
differ
consid
signific
p
valu
less
test
engag
mediat
hepat
injuri
mice
treat
lpsgaln
measur
level
serum
alt
ast
differ
time
point
intraven
administr
lpsgaln
mice
stimul
liver
inflamm
associ
alter
level
serum
alt
ast
level
show
signific
increas
h
lpsgalntreat
contrast
h
h
signific
increas
serum
level
alt
ast
detect
lpsgalntreat
versu
control
elev
serum
concentr
well
alt
ast
significantli
greater
h
fig
thereaft
increas
alt
ast
level
reduc
time
treatment
data
shown
coeffici
correl
alt
level
show
strongli
mutual
relat
find
suggest
contribut
hepat
injuri
mice
treat
lpsgaln
led
us
dissect
contribut
process
histolog
examin
liver
lpsgalntreat
mice
reveal
sign
inflammatori
liver
damag
fig
hematoxylin
eosin
stain
section
sign
acut
liver
injuri
damag
hapatocyt
found
mice
control
fig
h
treatment
fig
h
injur
hepatocyt
scatteredli
distribut
within
lobul
fig
numer
inflammatori
foci
observ
pericentr
area
consist
infiltr
cell
includ
neutrophil
monocytesmacrophag
injur
hepatocyt
h
treatment
fig
contrari
injur
foci
consider
reduc
h
fig
wherea
elev
serum
concentr
alt
ast
continu
time
fig
b
gltreatment
perform
min
lpsgaln
inject
strongli
inhibit
inflammatori
foci
fig
enhanc
serum
level
alt
ast
fig
j
induc
h
inject
lpsgaln
determin
cellular
local
remnant
treatment
immunohistochem
stain
perform
paraffin
section
retriev
mice
variou
hour
lpsgaln
treatment
fig
immunohistochemistri
antibodi
reveal
distinct
nuclear
express
hepatocyt
control
mice
fig
h
treatment
fig
stage
cell
express
weak
cytoplasm
immunoreact
deposit
seen
extracellular
milieu
immunoreact
nuclei
began
suppress
h
concomit
administr
lpsgaln
fig
h
intranuclear
immunoreact
product
remark
reduc
fig
aberr
extracellular
express
demonstr
fig
stage
immunolabel
restrict
inflammatori
pericentr
area
pronounc
cytoplasm
addit
extracellular
express
appear
coincid
progress
inflam
liver
fig
h
distinct
nuclear
express
significantli
increas
hepatocyt
fig
although
occat
hepatocyt
remain
express
cytoplasm
fig
gltreatment
strongli
inhibit
immunoreact
express
cytoplasm
addit
extracellular
fig
decreas
intranuclear
immunoreact
product
fig
induc
inject
lpsgaln
examin
immunoreact
express
activ
kupffer
dendrit
cell
respons
lpsgalninduc
hepat
injuri
use
doubleimmunofluoresc
stain
fig
fig
cell
popul
distribut
inflammatori
pericentr
foci
intens
label
white
arrow
fig
l
white
arrow
fig
white
arrow
fig
h
lpsgalntreat
furthermor
part
kupffer
dendrit
cell
simultan
immunolabel
white
arrow
fig
n
respect
result
indic
activ
kupffer
dendrit
cell
express
cytoplasm
lpsgalninduc
hepat
injuri
acetyl
posttransl
modif
influenc
protein
local
function
hyperacetyl
shift
equilibrium
predomin
nuclear
locat
toward
cytosol
accumul
lead
subsequ
releas
determin
acetyl
statu
mous
liver
subject
concomit
administr
lpsgaln
level
acetyl
assess
immunohistochemistri
polyclon
antibodi
acetylatedlysin
fig
nuclear
immunoreact
product
label
hepatocyt
control
mice
fig
g
liver
cell
nuclear
immunoreact
acetylatedlysin
significantli
increas
number
h
treatment
fig
g
cell
express
weak
cytoplasm
immunoreact
acetylatedlysin
deposit
acetylatedlysin
seen
extracellular
milieu
h
concomit
administr
lpsgaln
immunoreact
intens
acetylatedlysin
nuclei
began
suppress
immunolabel
product
extracellularli
stain
pericentr
area
fig
intranuclear
immunoreact
product
remark
reduc
h
fig
g
aberr
extracellular
acetylatedlysin
express
frequent
found
fig
stage
immunolabel
acetylatedlysin
exclus
restrict
inflammatori
pericentr
area
pronounc
cytoplasm
addit
extracellular
acetylatedlysin
express
seem
coincid
progress
inflamm
liver
compar
fig
fig
timedepend
chang
distribut
pattern
immunolabel
compar
fig
fig
h
distinct
nuclear
express
acetylatedlysin
significantli
increas
liver
cell
fig
although
liver
cell
express
cytoplasm
acetylatedlysin
pericent
area
fig
liver
mice
treat
lpsgaln
administr
gl
remark
reduc
immunoreact
cytoplasm
extracellular
respons
acetylatedlysin
fig
show
signific
increas
number
nuclear
immunoreact
product
acetylatedlysin
fig
data
suggest
treatment
gl
suppress
transloc
extracellular
milieu
blockad
acetyl
inhibit
rapid
activ
proinflammatori
pathway
accompani
lpsgalninduc
liver
injuri
howev
mechan
govern
transloc
recogn
injur
liver
induc
inject
lpsgaln
remain
unknown
lpsgalntreat
caus
temporari
increas
number
hepatocyt
acetylatedlysin
nucleu
fig
conduct
colorimetr
assay
assess
nuclear
cytoplasm
histon
deacetylas
hdac
activ
lpsgalninduc
liver
injuri
cytoplasm
fig
nuclear
fig
hdac
activ
increas
liver
tissu
anim
subject
lpsgaln
gllpsgaintreat
compar
baselin
anim
signific
thu
current
data
support
past
work
hypothesi
decreas
nuclear
cytoplasm
hdac
activ
due
lpsgalntreat
shift
equilibrium
predomin
nuclear
locat
toward
cytosol
accumul
lead
subsequ
releas
induc
hepat
injuri
rage
far
identifi
implic
signal
evalu
involv
rage
receptor
measur
kinet
mrna
level
receptor
induc
lpsdgalntreat
use
real
time
pcr
fig
lpsgaln
induc
signific
decreas
mrna
level
rage
fig
wherea
significantli
stimul
increas
mrna
fig
addit
administr
gl
becom
respons
rage
mice
treat
lpsgaln
fig
b
consequ
find
indic
lpsgalninduc
hepat
injuri
might
caus
extracellularli
releas
via
receptor
apoptot
liver
cell
distribut
pattern
examin
use
tunelmethod
expect
tunelposit
cell
observ
liver
salineinject
control
mice
fig
contrari
number
tunelposit
cell
sharpli
delin
mass
crescent
condens
chromatin
identifi
inflammatori
pericentr
area
h
postinject
lpsgaln
fig
number
tunelposit
cell
significantli
increas
pericentr
area
lpsgalntreat
liver
compar
control
fig
intraperiton
administr
gl
significantli
reduc
number
tunellabel
cell
pericentr
area
compar
mice
treat
lpsdgaln
fig
current
result
mous
liver
injuri
intox
lpsgaln
might
caus
apoptosi
hepatocyt
might
improv
inhibit
apoptot
cell
death
due
inject
gl
next
explor
fluctuat
express
gene
regul
apoptot
cell
death
lpsgaininjur
liver
use
gene
microarray
analysi
microarray
analysi
reveal
express
pattern
gene
influenc
inject
lpsgain
lpsgaln
gl
fig
express
level
downregul
lpsgalninject
liver
injuri
recov
inject
gl
contrari
express
pattern
upregul
lpsgaln
treatment
restor
inject
gl
valid
result
microarray
analysi
perform
semiquantit
pcr
use
cdna
control
lpsgalninjur
gllpsgalntreat
liver
inject
lpsgaln
express
level
mrna
significantli
decreas
respect
express
level
mrna
significantli
recov
respect
administr
gl
fig
c
also
express
level
mrna
significantli
increas
lpsgalninject
liver
injuri
mrna
significantli
downregul
administr
gl
hand
mrna
level
significantli
affect
lpsgaln
gllpsgalntreat
fig
find
appar
show
lpsgalninduc
hepat
injuri
anim
model
might
brought
apoptosi
signal
howev
remain
unknown
whether
implic
apoptosi
signal
liver
remnant
treat
lpsgaln
confirm
function
protein
experiment
model
chromatin
immunoprecipit
chip
assay
perform
use
transcript
factor
search
web
site
design
sever
respect
pcr
primer
amplifi
promot
region
could
amplifi
expect
size
band
clone
pcr
product
vector
confirm
sequenc
use
primer
amplifi
promot
region
bp
chip
assay
analysi
reveal
protein
strongli
bound
promot
sequenc
lpsgalninject
liver
injuri
fig
could
detect
combin
promot
sequenc
use
analysi
data
shown
furthermor
administr
gl
remark
inhibit
bind
promot
sequenc
fig
mous
liver
injuri
induc
lipopolysaccharidedgalactosamin
lpsgaln
commonli
use
promis
anim
model
elucid
mechan
clinic
dysfunct
evalu
efficaci
hepatoprotect
multipl
pathway
converg
signal
activ
endogen
inflammatori
cell
within
liver
well
upregul
key
adhes
molecul
chemokin
mediat
migrat
inflammatori
cell
peripheri
foci
activ
inflamm
perturb
remnant
set
motion
facet
immuneinflammatori
respons
join
forc
stimul
tissuedestruct
pathway
failur
regen
program
studi
provid
first
vivo
evid
show
involv
apoptosi
hepatocyt
caus
lpsgalntreat
administr
gl
significantli
improv
hepat
injuri
parallel
suppress
exagger
apoptot
cell
death
enhanc
express
regeneratiom
mediat
multifunct
protein
earliest
function
describ
nonhiston
dnabind
nuclear
protein
bind
dna
sequenceindepend
manner
modifi
dna
structur
facilit
transcript
replic
repair
function
essenti
surviv
mice
die
hypoglycemia
within
hour
birth
recent
identifi
novel
inflammatori
cytokin
late
mediat
endotoxin
lethal
mice
extracellular
activ
larg
number
differ
physiolog
respons
differ
cell
type
may
releas
activ
secret
variou
cell
includ
activ
monocytesmacrophag
neutrophil
apoptot
cell
passiv
danger
signal
necrot
cell
system
produc
earli
inflammatori
respons
lead
amplif
secret
activ
secret
phagocyt
display
delay
kinet
current
experiment
model
could
recogn
earliest
biochem
histolog
damag
h
stage
lpsgalntreat
thu
delay
activ
releas
may
partli
explain
find
present
immunohistochemistri
reveal
intens
express
focus
inflammatori
foci
close
central
vein
area
suscept
lpsgalntreat
although
immunoreact
product
reach
maximum
h
level
serum
maxim
h
increas
serum
level
seem
occur
littl
later
patholog
damag
liver
tissu
induc
lpsgalntreat
thu
observ
efflux
appear
deriv
mainli
injur
hepat
tissu
result
ident
data
obtain
patient
acut
liver
failur
lpsgalninduc
liver
injuri
kinet
distinct
obtain
previou
studi
line
previou
work
fail
find
associ
variou
cytokin
might
reflect
complex
inflammatori
respons
clinic
set
role
receptor
advanc
glycat
end
product
rage
ligand
maintain
amplifi
inflamm
recent
highlight
rage
member
immunoglobulin
superfamili
interact
ligand
enrich
flame
milieu
includimg
carboxymethyl
lysinemodifi
adduct
latter
member
famili
proinflammatori
cytokin
blockad
rage
employ
solubl
rage
srage
extracellular
ligandbind
domain
rage
suppress
injuri
hepat
ischemiareperfus
well
induct
collageninduc
arthriti
mice
sensit
challeng
bovin
type
ii
collagen
studi
howev
express
level
rage
mrna
convers
decreas
administr
lpsgaln
gltreatment
exert
influenc
express
contrast
express
level
mrna
significantli
increas
lpsgalninduc
hepat
injuri
compar
control
gl
inhibit
gl
bind
directli
two
hmg
box
shown
nmr
fluoresc
studi
modest
effect
gl
intranuclear
function
agreement
absenc
cytotox
even
high
gl
concentr
good
pharmacolog
toler
gl
rodent
human
interestingli
administr
gl
caus
releas
apoptot
chromatin
impli
produc
paradox
inflammatori
respons
apoptot
cell
current
result
suggest
effect
mechan
gl
downstream
initi
tlr
activ
injur
liver
induc
lpsgaln
inject
insid
cell
bind
dna
regul
transcript
whrea
outsid
cell
serv
cytokin
mediat
late
effect
lp
present
studi
doubleimmunofluoresc
analysi
reveal
activ
macrophag
dendrit
cell
express
cytoplasm
lpsgalninduc
hepat
injuri
respect
monocyt
macrophag
extens
acetyl
upon
activ
lp
caus
local
protein
cytosol
cytosol
concentr
secretori
lysosom
secret
cell
receiv
appropri
second
signal
movement
extracellular
space
demonstr
macrophag
stimul
lp
well
cell
undergo
necrosi
apoptosi
previou
paper
analys
use
tunelmethod
oligonucleosomebound
dna
elisa
microdissectionmethod
show
degre
hepat
injuri
associ
substanti
number
cell
undergo
apoptosi
acut
hepat
induc
singl
inject
lpsgaln
gltreatment
suppress
apoptosi
liver
cell
induc
lp
dgalnsensit
mice
role
precis
mechan
apoptot
cell
death
hepatocyt
experiment
hepat
remain
unknown
assum
implic
signal
pathway
regul
apoptosi
assess
acetyl
inflammatori
hepat
specimen
conduct
immunohistochem
analysi
use
antibodi
acetylatedlysin
analysi
reveal
nuclear
immunoreact
product
hepat
cell
control
mice
hepatocyt
nuclear
immunoreact
acetylatedlysin
increas
number
h
concomit
administr
lpsgaln
decreas
h
h
aberr
extracellular
acetylatedlysin
express
label
mainli
restrict
pericentr
inflammatori
area
h
distinct
nuclear
express
acetylatedlysin
increas
hepat
cell
although
hepatocyt
remain
express
cytoplasm
acetylatedlysin
pericentr
area
administr
gl
strongli
inhibit
immunoreact
acetylatedlysin
lpsgalninduc
liver
injuri
immunohistochem
analysi
acetylatedlysin
use
experi
show
administr
gl
may
inhibit
acetyl
lysin
liver
remnant
lpsgalninduc
mice
abil
gl
suppress
alt
level
observ
administ
min
min
lpsgaln
gltreatment
littl
effect
alt
level
administ
h
lpsgaln
inject
thu
inhibitori
effect
gl
lpsgalninduc
liver
injuri
might
due
bind
directli
acetyl
acetyl
shown
involv
regul
dna
bind
properti
along
subcellular
locat
vitro
experi
shown
lysin
residu
repres
function
nuclear
local
signal
macrophag
also
recent
mutat
analysi
abil
protein
bind
bend
dna
report
role
lysin
target
site
acetyl
fulllength
truncat
tailless
protein
respect
serum
releas
follow
liver
ischemiareperfus
ir
vivo
acetyl
hepatocyt
expos
oxid
stress
vitro
also
releas
acetyl
level
acetyl
increas
concomit
decreas
total
nuclear
histon
deacetylas
hdac
activ
suggest
suppress
hdac
activ
contribut
increas
acetyl
releas
oxid
stress
hepatocyt
studi
isoform
demonstr
critic
regul
acetyl
releas
activ
decreas
nucleu
hepatocyt
undergo
oxid
stress
addit
knockdown
sirna
promot
transloc
releas
furthermor
shuttl
nucleu
cytoplasm
respons
oxid
stress
result
decreas
hdac
activ
nucleu
contrari
present
experi
find
decreas
cytoplasm
nuclear
hdac
activ
inject
lpsgaln
addit
administr
gl
induc
signific
increas
nuclear
hdac
activ
phosphoryl
anoth
regulatori
mechan
influenc
subcellular
locat
recent
shown
phosphoryl
calciumcalmodulin
protein
kinas
iv
caus
nucleartocytoplasm
shuttl
releas
lpsstimul
macrophag
damag
cell
activ
innat
immun
recruit
inflammatori
cell
collect
releas
danger
signal
known
damageassoci
molecular
pattern
damp
one
molecul
implic
earli
mediat
organ
damag
ischemiareperfus
ir
injuri
hemorrhag
shock
well
late
mediat
lethal
endotox
shock
case
cell
activ
secret
appear
immun
cell
macrophag
natur
killer
cell
dendrit
cell
howev
becom
increasingli
clear
nonimmun
parenchym
cell
also
particip
activ
secret
also
shown
neutral
antibodi
amellior
liver
ir
injuri
therebi
suggest
therapeut
benefit
block
activ
releas
minim
irassoci
damag
contrast
preliminari
work
present
result
intraven
inject
ngmous
hour
lpsgalntreat
alon
precipit
altast
activ
fig
furthermor
intraven
inject
neutral
antibodi
mgkg
amelior
increas
serum
altast
activ
lpsgalninjur
mice
fig
addit
find
express
level
mrna
lpsgalninduc
hepat
injuri
significantli
increas
compar
control
rage
mrna
convers
decreas
hepat
injuri
consid
togeth
data
acut
hepat
injuri
stimul
singl
inject
lpsgaln
might
caus
releas
extracellular
milieu
nonhematopoiet
cell
hepatocyt
activ
macrophagesdendrit
cell
current
investig
numer
apoptot
cell
observ
pericentr
area
lpsgalntreat
liver
understand
mechan
hepatocyt
apoptosi
promot
lpsgalninduc
hepat
injuri
explor
fluctuat
express
gene
associ
regul
apoptot
cell
death
use
gene
microarray
analysi
fig
studi
clinic
syndrom
observ
lpsgalntreat
anim
associ
diffus
hepatocyt
apoptosi
prevent
administr
gl
base
result
obtain
microarray
analysi
furthermor
express
pattern
gene
influenc
inject
lpsgain
lpsgain
gl
examin
quantit
pcr
use
cdna
control
lpsgaininject
gllpsgaintreat
liver
remnant
examin
bind
protein
gene
perform
analysi
chip
assay
reveal
protein
intens
bound
promot
sequenc
lpsgaininject
liver
injuri
could
detect
combin
promot
sequenc
gene
furthermor
administr
gl
strongli
inhibit
bind
promot
sequenc
gst
glutachion
transferas
superfamili
ubiquit
intracellular
enzym
catalyz
conjug
glutathion
wide
rang
exogen
endogen
compound
includ
chemic
carcinogen
therapeut
drug
oxid
stress
product
new
member
gst
structur
famili
novel
catalyt
activ
function
recent
discov
mous
inde
identifi
overexpress
mous
lymphoma
cell
line
present
resist
varieti
chemotherapeut
transfect
sirna
transfect
hela
cell
present
mark
increas
apoptosi
compar
control
suggest
play
antiapoptot
role
overexpress
associ
activ
surviv
pathway
includ
akt
kinas
cell
surviv
factor
extracellular
signalregul
kinas
erk
cell
surviv
prolifer
factor
antiapoptot
pathway
cjun
ntermin
kinas
jnk
apoptosi
blockad
factor
immunohistochemistri
lpstreat
liver
remnant
show
remark
decreas
nuclear
reactiv
spars
reactiv
cytoplasm
antibodi
activ
h
compar
control
gltreat
remnant
fig
although
activ
associ
potent
inflammatori
respons
hepat
injuri
key
role
factor
inhibit
apoptosi
liver
also
demonstr
definit
experiment
conclus
mous
liver
injuri
induc
singl
inject
lpsgaln
protein
appear
implic
direct
andor
indirect
inhibit
signal
pathway
associ
antiapoptosi
ie
downregul
stimul
apoptosi
hepatocyt
rather
act
proinflammatori
factor
experiment
model
howev
exclud
possibl
addit
lpstreatment
induc
releas
extracellular
milieu
precipit
hepat
inflamm
receptor
andor
rage
addit
role
gl
disclos
studi
report
gl
treatment
inhibit
prolifer
migrat
cell
stimul
cytokin
well
format
blood
vessel
reduc
inflammatori
condit
